Related references
Note: Only part of the references are listed.Imatinib Mesylate as Add-on Therapy for Pulmonary Arterial Hypertension Results of the Randomized IMPRES Study
Marius M. Hoeper et al.
CIRCULATION (2013)
Systemic Sclerosis-associated Pulmonary Arterial Hypertension
Jerome Le Payec et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2010)
Imatinib in Pulmonary Arterial Hypertension Patients with Inadequate Response to Established Therapy
Hossein A. Ghofrani et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2010)
Standard PAH therapy improves long term survival in CTEPH patients
Hans-Juergen Seyfarth et al.
CLINICAL RESEARCH IN CARDIOLOGY (2010)
New therapies for pulmonary arterial hypertension: an update on current bench to bedside translation
Laurence Dewachter et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2010)
Guidelines for the diagnosis and treatment of pulmonary hypertension
Nazzareno Galie et al.
EUROPEAN HEART JOURNAL (2009)
Updated Evidence-Based Treatment Algorithm in Pulmonary Arterial Hypertension
Robyn J. Barst et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
Pulmonary hypertension
Gorev Grubu Uyeleri et al.
TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY (2009)
Portopulmonary hypertension -: Survival and prognostic factors
Jerome Le Pavec et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2008)
Combined Tyrosine and Serine/Threonine Kinase Inhibition by Sorafenib Prevents Progression of Experimental Pulmonary Hypertension and Myocardial Remodeling
Martina Klein et al.
CIRCULATION (2008)
Chronic thromboembolic pulmonary hypertension
MM Hoeper et al.
CIRCULATION (2006)
Prevalence and outcomes of pulmonary arterial hypertension in advanced idiopathic pulmonary fibrosis
CJ Lettieri et al.
CHEST (2006)
Three-year efficacy and safety results from a study of everolimus versus mycophenolate mofetil in de novo renal transplant patients
S Vítko et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2005)
Imatinib for the treatment of pulmonary arterial hypertension
HA Ghofrani et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Everolimus with optimized cyclosporine dosing in renal transplant recipients: 6-month safety and efficacy results of two randomized studies
S Vitko et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2004)
Cardiac allograft vasculopathy: advances in understanding its pathophysiology, prevention, and treatment
SP Pinney et al.
CURRENT OPINION IN CARDIOLOGY (2004)
Everolimus - A proliferation signal inhibitor targeting primary causes of allograft dysfunction
JM Kovarik
DRUGS OF TODAY (2004)
Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients
HJ Eisen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
40-O-(2-hydroxyethyl)-rapamycin attenuates pulmonary arterial hypertension and neointimal formation in rats
T Nishimura et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2001)
Triptolide attenuates pulmonary arterial hypertension and neointimal formation in rats
JL Faul et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2000)
Share Paper
